Clinical Trial Update: Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating chemotherapy with or without trastuzumab in metastatic osteosarcoma completed, examining whether adding trastuzumab provides any benefi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Osteosarcoma | Phase 2 | Status: COMPLETED